Buserelin treatment of advanced prostatic cancer: a phase II study.
Veronesi A, Lo Re G, Dal Bo V, Magri MD, Della Valentina M, Talamini R, Merlo A, Francini M, Monfardini S.
Veronesi A, et al. Among authors: talamini r.
Med Oncol Tumor Pharmacother. 1989;6(4):255-7. doi: 10.1007/BF02985157.
Med Oncol Tumor Pharmacother. 1989.
PMID: 2515400